Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quality Experts Advise Industry To Move Products To Local Sites In Responding To COVID-19

Executive Summary

Quality experts with AstraZeneca and Thermo Fisher describe how their companies are responding to the COVID-19 pandemic – but urge industry not to lose focus on monitoring unrelated drug products.

You may also be interested in...



Canada Supplements COVID-19 Testing By Invoking Emergency Provisions

The Canadian government has issued an interim order authorizing the import and sale of two new diagnostic test kits for COVID-19. Other companies making tests for the virus can apply for authorization under the order.

Quality Desert: How An Academic Minor In Quality Could Be The Key To Quenching Industry's Thirst For QA Professionals

The medtech industry is facing a quickening problem of older workers retiring, leaving holes to fill in quality departments around the globe. In response, a Medical Device Innovation Consortium (MDIC) "Quality as a Career" workgroup partnered with Pathway for Patient Health to create a Quality Science Education framework that can be used by any university or college in the world free-of-charge. The program, packaged as an academic minor, includes six quality-focused courses for students to complete. Xavier University in Cincinnati, OH, recently became the first school to use the program curriculum.

Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others

Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS141948

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel